FNAM Stock Price, Chart, Stats & News

Evolutionary Genomics, Inc.
Save
Evolutionary Genomics, Inc. (FNAM) does not currently pay a dividend.
1,331
Market cap
–
Current P/E
–
Forward P/E
FNAM chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
Evolutionary Genomics, Inc., together with its subsidiaries, engages in the research and identification of positively selected genes in humans, animals, and commercial crops. The company develops Adapted Traits Platform, a technology platform to identify genes for enhancing crop plant traits, such as yield, sugar content, biomass, drought tolerance, and pest/disease resistance. It serves governmental organizations, non-profit foundations, and commercial entities.
Similar securities
Based on sector and market capitalization
Report issue





